Developer of hydrogel-derived nanoparticle system for topical applications. The company has developed a patented drug delivery system Nanopods, a hydrogel-derived nanoparticle system. The system can be used to deliver payloads such as nitric oxide, curcumin, cannabis, siRNA, iron, and melanin topically. The company was founded in 2017 and headquartered in Greenville, United States. It has raised $9.4M in series b funding, with backing from NIH, VentureSouth, New York Angels, SCRA, and others. The company operates in the Life Sciences - Drug Delivery, High Tech - Nanotechnology space. Its offerings span Drug Delivery - Topical. The company's offerings encompass Drug Delivery - Topical.
← All startups
Zyl Therapeutics
Series BDeveloper of hydrogel-derived nanoparticle system for topical applications. The company has developed a patented drug delivery system Nanopods, a hydrogel-derived nanoparticle system. The system can be used to deliver payloads such as nitric oxide, curcumin, cannabis, siRNA, iron, and melanin topically. The company was founded in 2017 and headquartered in Greenville, United States. It has raised $9.4M in series b…
About
Business model
Nanotechnology > Nanoenabled Products > Life Science > Drug Delivery > Encapsulation,
Drug Delivery > Topical
Institutional investors
NIHVentureSouthNew York AngelsSCRABoston Harbor AngelsCowtown AngelsHBS Alumni Angels of Greater New YorkNIH SBIR/STTRASAPChemical Angel NetworkHHSArcview Collective FundKTECH CapitalAEON FoundryMohan Growth Partners
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ See who's investing in Life Sciences — full fund directory with check size and geography.